Article
The Presence of CD11c+ B Cells with Potent Effector Memory Phenotype in Lung Adenocarcinoma Correlates with Overall Patient Survival.
Cancer immunology research - 4 May 2026
Sambanthamoorthy Sharmila, Ren Yan, Galvez Tatiana K, King Benjamin, Liu Scot D, Kidd Brian A, Law Debbie A, Baumgarth Nicole
Abstract excerpt
Tumor-infiltrating B lymphocytes (TIL-B) are increasingly recognized as favorable prognostic markers in multiple cancer types, and the mechanisms underlying this are being actively investigated. In this study of TIL-Bs, we identified CD79A as a reliable quantifier of B lymphocytes and evaluated transcriptomic data for 15 distinct tumors using 8,720 samples of treatment naïve patients from The Cancer Genome Atlas...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
